Financials in USD. Standardized financial statements.
A compact view of how Guardian Pharmacy Services, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.45B | $1.23B | $1.05B | $908.91M | $792.07M | $735.96M | $698.29M | $600.37M |
| Revenue Growth? | +17.9% | +17.4% | +15.1% | +14.8% | +7.6% | +5.4% | +16.3% | 0.0% |
| Cost of Revenue? | $1.17B | $984.04M | $837.88M | $723.04M | $630.81M | $588.96M | $554.83M | $477.33M |
| Gross Profit? | $282.04M | $244.37M | $208.31M | $185.87M | $161.26M | $147.00M | $143.46M | $123.03M |
| Gross Margin? | +19.5% | +19.9% | +19.9% | +20.4% | +20.4% | +20.0% | +20.5% | +20.5% |
| Operating Expenses? | $193.13M | $307.29M | $167.36M | $133.88M | $131.12M | $114.94M | $109.36M | $97.10M |
| Operating Income? | $88.91M | -$62.92M | $40.95M | $51.99M | $30.15M | $32.06M | $34.10M | $25.93M |
| EBITDA? | $111.25M | -$43.43M | $58.81M | $68.15M | $46.49M | $49.07M | $49.47M | $38.30M |
| Income Before Tax | $73.42M | -$66.48M | $37.72M | $49.66M | $28.33M | $29.66M | $31.37M | $23.27M |
| Income Tax Expense | $24.46M | $4.56M | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | $49.22M | -$87.29M | $23.90M | $35.42M | $16.31M | $19.94M | $21.75M | $14.68M |
| EPS? | $0.79 | $-1.77 | $0.39 | $0.58 | $0.27 | $0.33 | $0.36 | $0.24 |
| Diluted EPS? | $0.78 | $-1.77 | $0.39 | $0.58 | $0.27 | $0.33 | $0.36 | $0.24 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality